IONS vs SDGR · rev $226.6M vs rev $255.9M
Ionis Pharmaceuticals Inc (IONS) versus Schrodinger Inc (SDGR) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Schrodinger Inc (SDGR) is a health information services company listed on NASDAQ.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported SDGR revenue for 2025-12-31 was $255.9M. Net income was -$103.3M. Revenue was up 23.3% from 2024-12-31 to 2025-12-31. SDGR currently screens at market cap $1.16B.
IONS currently screens at market cap $12.28B. SDGR currently screens at market cap $1.16B.
Not investment advice. Open the IONS and SDGR stock pages for the full models.
Not investment advice.